Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Non-Current Assets: 2013-2025

Historic Non-Current Assets for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $62.9 million.

  • Fortress Biotech's Non-Current Assets rose 54.15% to $62.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.9 million, marking a year-over-year increase of 54.15%. This contributed to the annual value of $53.9 million for FY2024, which is 6.63% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Non-Current Assets is $62.9 million, which was up 27.08% from $49.5 million recorded in Q2 2025.
  • Fortress Biotech's 5-year Non-Current Assets high stood at $106.6 million for Q3 2021, and its period low was $40.8 million during Q3 2024.
  • Over the past 3 years, Fortress Biotech's median Non-Current Assets value was $51.2 million (recorded in 2025), while the average stood at $51.5 million.
  • Per our database at Business Quant, Fortress Biotech's Non-Current Assets surged by 83.42% in 2021 and then crashed by 38.52% in 2022.
  • Fortress Biotech's Non-Current Assets (Quarterly) stood at $50.0 million in 2021, then grew by 27.63% to $63.9 million in 2022, then declined by 20.93% to $50.5 million in 2023, then rose by 6.63% to $53.9 million in 2024, then surged by 54.15% to $62.9 million in 2025.
  • Its Non-Current Assets was $62.9 million in Q3 2025, compared to $49.5 million in Q2 2025 and $51.2 million in Q1 2025.